Campbell & Co. Investment Adviser »

Oric Pharmaceuticals shares owned by Campbell & Co. Investment Adviser

Quarter-by-quarter ownership of Oric Pharmaceuticals (ORIC) shares owned by Campbell & Co. Investment Adviser from 13F filings

Historical chart of Campbell & Co. Investment Adviser investment in Oric Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Oric Pharmaceuticals held by Campbell & Co. Investment Adviser consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oric Pharmaceuticals by Campbell & Co. Investment Adviser

Quarter filed Position value Share count Share price at filing
2024-09-30 $279k 27k 10.25
2024-03-31 $1.3M 97k 13.75

More positions owned by Campbell & Co. Investment Adviser

Workday Common Stock (WDAY)
PepsiCo Common Stock (PEP)
Msci Common Stock (MSCI)
Amphenol Corp Common Stock (APH)
Everest Group Common Stock (EG)
Cognizant Technology Solutions Common Stock (CTSH)
Tenable Holdings Common Stock (TENB)
Marsh & McLennan Cos Common Stock (MMC)
Intercontinental Exchange Common Stock (ICE)
Allegion Common Stock (ALLE)
Maximus Common Stock (MMS)
Janus Henderson Group Common Stock (JHG)
Royal Bank of Canada Common Stock (RY)
Portland General Electric Common Stock (POR)
Equifax Common Stock (EFX)

View all positions for Campbell & Co. Investment Adviser

Top funds holding Oric Pharmaceuticals

Nextech Invest
BlackRock
BlackRock
VR Adviser
Frazier Life Sciences Management
Viking Global Investors
Column Group
EcoR1 Capital
Vanguard Group
State Street Corporation
Commodore Capital
Boxer Capital
NEA Management Company
First Turn Management
Avidity Partners Management

View all funds holding Oric Pharmaceuticals